Ravi Kumar Singisetti, the Chief Executive Officer of $CTSH, sold 5,400 shares of the company on 08-04-2025 for an estimated $383,675. We received data on the trade from a recent SEC filing. This was a sale of approximately 7.6% of their shares of this class of stock. Following this trade, they now own 65,618 shares of this class of $CTSH stock.
$CTSH Insider Trading Activity
$CTSH insiders have traded $CTSH stock on the open market 6 times in the past 6 months. Of those trades, 0 have been purchases and 6 have been sales.
Here’s a breakdown of recent trading of $CTSH stock by insiders over the last 6 months:
- JOHN SUNSHIN KIM (CLO, CAO & Corporate Secretary) has made 0 purchases and 2 sales selling 10,000 shares for an estimated $819,185.
- SURYA GUMMADI (President - Americas) sold 5,600 shares for an estimated $399,743
- RAVI KUMAR SINGISETTI (Chief Executive Officer) sold 5,400 shares for an estimated $383,675
- MICHAEL PATSALOS-FOX sold 3,225 shares for an estimated $253,867
- LEO S. JR. MACKAY sold 1,600 shares for an estimated $139,856
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$CTSH Hedge Fund Activity
We have seen 443 institutional investors add shares of $CTSH stock to their portfolio, and 508 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BLACKROCK, INC. removed 2,880,852 shares (-5.2%) from their portfolio in Q1 2025, for an estimated $220,385,178
- GOLDMAN SACHS GROUP INC added 2,459,645 shares (+56.6%) to their portfolio in Q1 2025, for an estimated $188,162,842
- CITADEL ADVISORS LLC added 2,379,058 shares (+226.8%) to their portfolio in Q1 2025, for an estimated $181,997,937
- FIL LTD removed 2,042,261 shares (-32.6%) from their portfolio in Q1 2025, for an estimated $156,232,966
- NOMURA HOLDINGS INC added 1,989,972 shares (+105.6%) to their portfolio in Q1 2025, for an estimated $152,232,858
- AMUNDI added 1,723,335 shares (+61.6%) to their portfolio in Q1 2025, for an estimated $131,835,127
- PACER ADVISORS, INC. added 1,710,433 shares (+2585.0%) to their portfolio in Q1 2025, for an estimated $130,848,124
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$CTSH Analyst Ratings
Wall Street analysts have issued reports on $CTSH in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- JP Morgan issued a "Overweight" rating on 07/28/2025
- Guggenheim issued a "Buy" rating on 07/18/2025
- Evercore ISI Group issued a "Outperform" rating on 07/17/2025
- Susquehanna issued a "Positive" rating on 05/01/2025
- Barclays issued a "Overweight" rating on 04/25/2025
To track analyst ratings and price targets for $CTSH, check out Quiver Quantitative's $CTSH forecast page.
$CTSH Price Targets
Multiple analysts have issued price targets for $CTSH recently. We have seen 12 analysts offer price targets for $CTSH in the last 6 months, with a median target of $89.0.
Here are some recent targets:
- Tien-Tsin Huang from JP Morgan set a target price of $93.0 on 07/28/2025
- Jonathan Lee from Guggenheim set a target price of $90.0 on 07/18/2025
- Bryan Keane from Deutsche Bank set a target price of $80.0 on 07/17/2025
- David Togut from Evercore ISI Group set a target price of $100.0 on 07/17/2025
- David Koning from Baird set a target price of $82.0 on 05/01/2025
- Keith Bachman from BMO Capital set a target price of $85.0 on 05/01/2025
- James Friedman from Susquehanna set a target price of $90.0 on 05/01/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
